WINSTROL 50 La Pharma

£70.00

WINSTROL 50 La Pharma is a stanozolol-based research compound formulated as 50mg oral tablets for laboratory analysis and in-vitro studies investigating androgenic receptor modulation pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
WINSTROL 50 La Pharma
WINSTROL 50 La Pharma
£70.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

WINSTROL 50 La Pharma — Research Summary

WINSTROL 50 La Pharma is a stanozolol-based research compound manufactured for in-vitro laboratory studies examining androgenic steroid mechanisms. This synthetic derivative of dihydrotestosterone represents a modified 17α-alkylated structure that researchers utilise to investigate androgen receptor binding characteristics and downstream cellular pathways. Scientists at Stroid UK Shop examine this compound alongside other SARMs and peptides to understand comparative androgenic modulation patterns in controlled laboratory environments.

Laboratory Applications

Research applications focus on stanozolol’s unique molecular properties as a DHT derivative with reduced 5α-reductase susceptibility. Laboratory studies examine its interaction with androgen receptors while investigating the structural modifications that distinguish it from parent testosterone compounds. Scientists analyse its binding affinity profiles and evaluate cellular response patterns in muscle and bone tissue models. The compound’s oral bioavailability makes it particularly valuable for pharmacokinetic research examining absorption, distribution, and metabolic pathways in controlled studies. Researchers also investigate its potential as a reference standard when studying stanozolol tablets and related synthetic androgenic compounds.

Technical Specifications

Product Specifications
Parameter Value
Active Compound Stanozolol
Strength per Tablet 50mg
Manufacturer La Pharma
Form Oral Tablets
Storage Requirements Room temperature, dry environment
CAS Number Verify with supplier
Molecular Formula Verify with supplier
Research Use In-vitro studies only

Research Compliance

This stanozolol research compound is manufactured exclusively for laboratory research purposes and in-vitro studies. Not approved for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must maintain appropriate laboratory safety protocols and ensure compliance with institutional research guidelines when handling this material.

Related